Asthma Data Innovation Demonstration Project (ADID)

David Van Sickle

Status: Completed

Conditions: Lung Diseases, Obstructive; Asthma; Hypersensitivity, Immediate; Lung Diseases; Respiratory Hypersensitivity; Respiratory Tract Diseases; Immune System Diseases; Bronchial Diseases; Hypersensitivity

Treatments: Device: Propeller Health intervention

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02162576

PH LVL - 40202

Details and patient eligibility

About

Propeller Health is collaborating with the City of Louisville and other local partners to carry out a focused demonstration project that will evaluate the effectiveness of the Propeller Health approach to asthma management while exploring means to use real-time data on asthma exacerbations in a public health setting. The Asthma Data Innovation Demonstration Project (ADID) will use wireless sensor technology to develop spatial and temporal data on the use of rescue inhalers by 120 study subjects with asthma in the Louisville metropolitan area. Propeller Health will process these data to support two general strategies.

Asthma self management: Rescue inhaler actuation data will be compiled into individualized feedback reports to support asthma self management. Propeller Health will combine information on individual rescue inhaler actuations with evidence-based asthma management tips into real-time reports that will be provided to subjects. ADID staff will evaluate any resulting improvements in asthma control that may be based on this information. Subjects may share reports with their healthcare providers.

Municipal purposes: The second strategy is to provide aggregated and de-identified, spatial and temporal asthma rescue inhaler actuation data to City personnel and authorized public health researchers in Louisville. These data will show the times and locations of the use of rescue inhalers by the 120 study subjects throughout the greater Louisville area. ADID staff will work with City personnel and researchers to investigate how this unprecedented level of detailed information on exacerbations can be used best to increase public awareness of environmental triggers while supporting public health surveillance efforts around respiratory diseases.

Enrollment: 95 patients

Sex: All

Ages: 5+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Self-reported provider diagnosis of asthma
• Prescription for Short Acting Beta Agonist (SABA) at study intake

Exclusion criteria

• Subject is under the age of 5 at the beginning of the study
• Subject does not speak English
• Subject does not have access to the Internet or email to receive reports
• Subject has substantial co-morbidity (self-reported provider diagnosis of COPD)

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

95 participants in 1 patient group

Propeller Health intervention group

Other group

Description:

All participants attached the Propeller sensor to their SABA medications and tracked the time and location of use for up to 13 months, to capture seasonal variation in medication use, symptoms and environmental triggers. The first 30-day run-in period served as a control period to assess levels of asthma control and SABA use; subject actuations were tracked, but participants and physicians did not receive their data or feedback. After the run-in period, participants received the full intervention for 12 months (see intervention for description).

Treatment:

Device: Propeller Health intervention